Vincerx Pharma, Inc. Board of Directors

Vincerx Pharma, Inc., a clinical-stage biopharmaceutical company, researches and develops therapies to address unmet medical needs for the treatment of cancer in the United States. The company is developing enitociclib, a cyclin-dependent kinase-9 inhibitor that is in Phase 1 clinical trials for treating patients with relapsed and refractory leukemia and lymphoid malignancies, as well as solid tumors and non-Hodgkin lymphoma; and VIP236, a small molecule drug conjugate that is in Phase 1 clinical trials to treat advanced or metastatic solid tumors. Its product candidates also include VIP943 in Phase 1 clinical trials for the treatment of relapsed/refractory acute myeloid leukemia, myelodysplastic syndrome, and B-cell acute lymphoblastic leukemia; and VIP924 in preclinical studies for the treatment of B-cell malignancies. Vincerx Pharma, Inc. was founded in 2019 and is based in Palo Alto, California.

Mr. Kevin Haas

Mr. Kevin Haas

Acting CFO, VP of Finance & Corporate Controller

Dr. Hans-Georg Lerchen Ph.D.

Dr. Hans-Georg Lerchen Ph.D.

Chief Scientific Officer

Ms. Karen Quarford M.B.A.

Ms. Karen Quarford M.B.A.

Vice President of Quality Operations & Compliance

Mr. Tom C. Thomas J.D.

Mr. Tom C. Thomas J.D.

Founder, General Counsel & Chief Legal Officer

Ms. Melissa Merrick SPHR

Ms. Melissa Merrick SPHR

Senior Director of People & Culture and Head of Human Resource

Ms. Gabriela Jairala

Ms. Gabriela Jairala

Vice President of Investor Relations & Corporate Communications and Chief of Staff

Dr. John C. Byrd M.D.

Dr. John C. Byrd M.D.

Founder & Chairman of Scientific Advisory Board

Dr. Beatrix Stelte-Ludwig Ph.D.

Dr. Beatrix Stelte-Ludwig Ph.D.

Executive Chief Development Officer

Dr. Raquel E. Izumi Ph.D.

Dr. Raquel E. Izumi Ph.D.

Co-Founder, Acting CEO, Secretary & Director

Dr. Ahmed M. Hamdy M.D.

Dr. Ahmed M. Hamdy M.D.

Co-Founder & Chairman

Leaving Board of Directors Review Your about to visit the following url Invalid URL

Loading...
Comments


Comment created.